The University of Waterloo is a leading global research-intensive university and home to transformational research and inspired learning. Waterloo researchers recently received more than $10 million as part of $693.8 million in funding awarded on June 14 to support discovery and applied research.
The news was shared by Yasir Naqvi, Parliamentary Secretary to the Minister of Health, and Ryan Turnbull, Parliamentary Secretary to the Deputy Prime Minister and Minister of Finance and Parliamentary Secretary to the Minister of Innovation, Science and Industry, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science, and Industry.
Four Canada Research Chairs were announced from the University of Waterloo, along with numerous researchers who have received funding under the following grants, scholarships and programs:
- Canada Foundation for Innovation: John R. Evans Leaders Fund
- PromoScience grant
- Natural Sciences and Engineering Research Council of Canada:
- Discovery Horizons program
- Discovery Grant program
- Discovery Launch Supplement
- Research Tools and Instruments (RTI) grant
The recent NSERC announcement is testament to Waterloo's research strength," said Charmaine Dean, vice-president, Research and International. "Thank you to the federal government for continuing to recognize the importance of funding scientific discovery and congratulations to the awardees who will advance cutting-edge research to the benefit of all Canadians."
The recipients have demonstrated research excellence in engineering, natural sciences, health sciences and social sciences. This funding will enable them to continue transforming societies, economies, technologies, sustainability and health for society to thrive in our complex future. Learn more about their work below.
Canada Research Chairs
Dr. Travis Craddock | Faculty of Science
$1.4 million
New Tier 1 Canada Research Chair in Quantum Neurobiology
Neuroinflammatory diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) are among the most serious health problems facing society today. They affect upwards of 700,000 Canadians costing the economy $11.6 billion annually. This is projected to double by 2030. Craddock's expertise in the emerging field of quantum biological modeling of sub-neural structures combined with his experience in the clinically focused modeling of neuroinflammatory illnesses will advance knowledge and enable the design of first-of-their-kind treatment strategies. The research will be aimed at mitigating cytoskeletal damage caused by neuroinflammation to improve the quality of life for millions of people worldwide.
